Telenursing and Remote Monitoring in Idiopathic Pulmonary Fibrosis (IPF) (NCT03562247) | Clinical Trial Compass
TerminatedNot Applicable
Telenursing and Remote Monitoring in Idiopathic Pulmonary Fibrosis (IPF)
Stopped: Principal Investigator left the institution and the study was closed with the IRB
United States31 participantsStarted 2018-08-01
Plain-language summary
Numerous studies show that remote monitoring and/or telenursing improves outcomes for patients especially those with chronic diseases. It is proposed that structured telenursing with non-invasive home monitoring of forced vital capacity and oxygen saturation in newly diagnosed patients with IPF will decrease hospitalizations for respiratory illness, increase compliance with therapies, and ultimately increase quality of life.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Patient must be newly diagnosed with IPF by a Vanderbilt pulmonologist according to the 2011 American Thoracic Society Guidelines. If the patient has been diagnosed by local pulmonologist and started on FDA-approved treatment, then must have been started on treatment within 6 months of Vanderbilt University Medical Center-based diagnosis.
✓. Willingness to complete Quality of Life and Compliance Questionnaires at 6-month intervals either via an on-line process (RED Cap survey) or paper-based.
✓. Willingness to participate in phone calls/video calls with the nurse practitioner or nurse case manager, if assigned to Arm 2 or Arm 3.
✓. Willingness to complete and monitor daily health assessments, if assigned to Arm 3.
✓. Willingness to share objective data via a provided electronic web-based portal, electronically via email, fax, or regular mail.
✓. Willingness to notify, or allow notification, of study involvement with local pulmonary practices.
Exclusion criteria
✕. Diagnosed with any other interstitial lung disease.
What they're measuring
1
The Number Hospitalization Events Resulting From a Respiratory Illness